IO Biotech Inc
IOBT2.104USD
-0.116-5.23%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
138.61MMarket Cap
LossP/E TTM
IO Biotech Inc
2.104
-0.116-5.23%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2020Q4
FY2020Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
7.46%-23.07M
13.91%-19.63M
-30.13%-20.81M
7.01%-16.98M
-69.72%-24.93M
-81.98%-22.80M
-19.79%-15.99M
-40.36%-18.26M
29.52%-14.69M
34.90%-12.53M
-64.53%-13.35M
---13.01M
---20.84M
-521.85%-19.24M
-275.25%-8.11M
---3.09M
---2.16M
Net income from continuing operations
-15.23%-22.42M
-19.67%-31.33M
-10.78%-24.02M
2.32%-20.69M
-14.16%-19.46M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
5.81%-20.07M
-1334.00%-15.69M
---18.50M
---17.20M
-734.34%-21.31M
68.64%-1.09M
---2.55M
---3.49M
Operating gains losses
-1.61%61.00K
8.47%64.00K
14.81%62.00K
18.18%65.00K
31.91%62.00K
-18.06%59.00K
315.38%54.00K
189.47%55.00K
--47.00K
--72.00K
--13.00K
--19.00K
----
----
----
----
----
Other non-cash items
-196.13%-536.00K
988.59%5.63M
-404.56%-1.54M
125.93%244.00K
80.39%-181.00K
243.21%517.00K
161.14%504.00K
-61.01%108.00K
-484.58%-923.00K
-3510.00%-361.00K
3760.00%193.00K
--277.00K
--240.00K
52.38%-10.00K
-44.44%5.00K
---21.00K
--9.00K
Change in working capital
74.81%-1.74M
249.72%4.38M
39.96%3.00M
55.18%1.75M
-615.87%-6.92M
-79.70%1.25M
902.25%2.14M
-70.52%1.13M
124.40%1.34M
474.23%6.17M
94.53%-267.00K
--3.83M
---5.50M
290.94%1.07M
-466.97%-4.88M
---563.00K
--1.33M
-Change in prepaid expenses
66.39%-700.00K
187.08%1.14M
352.41%846.00K
-195.12%-760.00K
-210.21%-2.08M
-237.11%-1.31M
-91.71%187.00K
-68.10%799.00K
266.23%1.89M
125.08%954.00K
181.39%2.26M
--2.50M
---1.14M
-665.39%-3.80M
-1076.06%-2.77M
---497.00K
--284.00K
Cash from non-recurring investing activities
Cash from operating activities
7.46%-23.07M
13.91%-19.63M
-30.13%-20.81M
7.01%-16.98M
-69.72%-24.93M
-81.98%-22.80M
-19.79%-15.99M
-40.36%-18.26M
29.52%-14.69M
34.90%-12.53M
-64.53%-13.35M
---13.01M
---20.84M
-521.85%-19.24M
-275.25%-8.11M
---3.09M
---2.16M
Investing cash flow
Net cash from continuing investing activities
154.55%28.00K
-90.18%11.00K
-58.33%10.00K
-69.23%12.00K
-92.57%11.00K
-67.91%112.00K
-79.66%24.00K
-63.55%39.00K
27.59%148.00K
132.67%349.00K
--118.00K
--107.00K
--116.00K
--150.00K
----
----
----
Capital expenditures
154.55%28.00K
-90.18%11.00K
-58.33%10.00K
-69.23%12.00K
-92.57%11.00K
-67.91%112.00K
-79.66%24.00K
-63.55%39.00K
27.59%148.00K
132.67%349.00K
--118.00K
--107.00K
--116.00K
--150.00K
----
----
----
Net cash flow from disposal of fixed assets
154.55%28.00K
-90.18%11.00K
-58.33%10.00K
-69.23%12.00K
-92.57%11.00K
-67.91%112.00K
-79.66%24.00K
-63.55%39.00K
27.59%148.00K
132.67%349.00K
--118.00K
--107.00K
--116.00K
--150.00K
----
----
----
Net cash flow from other investing activities
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-154.55%-28.00K
90.18%-11.00K
58.33%-10.00K
69.23%-12.00K
92.57%-11.00K
67.91%-112.00K
79.66%-24.00K
63.55%-39.00K
-27.59%-148.00K
-132.67%-349.00K
---118.00K
---107.00K
---116.00K
---150.00K
----
----
----
Financing cash flow
Cash flow from continuous financing activities
--0.00
100.00%0.00
-100.00%0.00
--0.00
--0.00
---10.00K
--71.87M
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--187.54M
-100.00%0.00
--0.00
--5.11M
Net cash flow from common stock issuance/repurchase
----
----
----
----
----
--0.00
--75.06M
----
----
----
----
----
----
--115.11M
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--0.00
--0.00
--84.19M
-100.00%0.00
--0.00
--5.12M
Net cash flow from other financing activities
----
----
----
----
----
---10.00K
---3.19M
----
----
100.00%0.00
--0.00
--0.00
--0.00
---11.77M
100.00%0.00
--0.00
---10.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--0.00
100.00%0.00
-100.00%0.00
--0.00
--0.00
---10.00K
--71.87M
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--187.54M
-100.00%0.00
--0.00
--5.11M
Net cash flow
Beginning cash balance
-57.97%60.30M
-51.47%80.45M
-8.47%101.02M
-8.19%118.25M
0.42%143.46M
9.46%165.77M
-35.23%110.36M
-31.55%128.79M
-32.55%142.86M
232.99%151.44M
211.20%170.39M
--188.17M
--211.80M
619.69%45.48M
1661.65%54.75M
--6.32M
--3.11M
Current period cash flow changes
8.99%-22.95M
9.66%-20.15M
-137.11%-20.56M
6.49%-17.23M
-79.27%-25.21M
-160.06%-22.31M
392.32%55.41M
-3.66%-18.43M
40.48%-14.06M
-105.16%-8.58M
-104.36%-18.95M
---17.78M
---23.63M
5807.69%166.32M
-388.85%-9.28M
---2.91M
--3.21M
Effect of exchange rate changes
157.46%154.00K
-185.06%-518.00K
156.89%256.00K
-83.97%-241.00K
-134.58%-268.00K
-85.83%609.00K
91.80%-450.00K
97.19%-131.00K
129.06%775.00K
334.68%4.30M
-372.29%-5.49M
---4.66M
---2.67M
-1117.22%-1.83M
-535.21%-1.16M
--180.00K
--267.00K
Ending cash balance
-68.41%37.35M
-57.97%60.30M
-51.47%80.45M
-8.47%101.02M
-8.19%118.25M
0.42%143.46M
9.46%165.77M
-35.23%110.36M
-31.55%128.79M
-32.55%142.86M
232.99%151.44M
--170.39M
--188.17M
6120.23%211.80M
619.69%45.48M
--3.41M
--6.32M
Free cash flow
7.39%-23.10M
14.28%-19.64M
-30.00%-20.82M
7.14%-16.99M
-68.10%-24.94M
-77.92%-22.91M
-18.92%-16.01M
-39.51%-18.30M
29.21%-14.84M
33.60%-12.88M
---13.47M
---13.12M
---20.96M
---19.39M
----
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
